{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:58:14Z","timestamp":1792681094322,"version":"4.5.0"},"reference-count":220,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG068226"],"award-info":[{"award-number":["R01AG068226"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG072090"],"award-info":[{"award-number":["R01AG072090"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P01AG066603"],"award-info":[{"award-number":["P01AG066603"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Senescence is a complex cell state characterized by stable cell cycle arrest and a unique secretory pattern known as the senescence-associated secretory phenotype (SASP). The SASP factors, which are heterogeneous and tissue specific, normally include chemokines, cytokines, growth factors, adhesion molecules, and lipid components that can lead to multiple age-associated disorders by eliciting local and systemic consequences. The skeleton is a highly dynamic organ that changes constantly in shape and composition. Senescent cells in bone and bone marrow produce diverse SASP factors that induce alterations of the skeleton through paracrine effects. Herein, we refer to bone cell-associated SASP as \u201cbone-SASP.\u201d In this review, we describe current knowledge of cellular senescence and SASP, focusing on the role of senescent cells in mediating bone pathologies during natural aging and premature aging syndromes. We also summarize the role of cellular senescence and the bone-SASP in glucocorticoids-induced bone damage. In addition, we discuss the role of bone-SASP in the development of osteoarthritis, highlighting the mechanisms by which bone-SASP drives subchondral bone changes in metabolic syndrome-associated osteoarthritis.<\/jats:p>","DOI":"10.1007\/s00223-023-01100-4","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T07:02:16Z","timestamp":1685516536000},"page":"68-82","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["\u201cBone-SASP\u201d in Skeletal Aging"],"prefix":"10.1007","volume":"113","author":[{"given":"Ching-Lien","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,31]]},"reference":[{"issue":"3","key":"1100_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/nbt0303-229b","volume":"21","author":"T von Zglinicki","year":"2003","unstructured":"von Zglinicki T, Petrie J, Kirkwood TB (2003) Telomere-driven replicative senescence is a stress response. Nat Biotechnol 21(3):229\u2013230","journal-title":"Nat Biotechnol"},{"issue":"5349","key":"1100_CR2","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1126\/science.279.5349.349","volume":"279","author":"AG Bodnar","year":"1998","unstructured":"Bodnar AG et al (1998) Extension of life-span by introduction of telomerase into normal human cells. Science 279(5349):349\u2013352","journal-title":"Science"},{"issue":"9","key":"1100_CR3","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/sj.onc.1201862","volume":"16","author":"SJ Robles","year":"1998","unstructured":"Robles SJ, Adami GR (1998) Agents that cause DNA double strand breaks lead to p16INK4a enrichment and the premature senescence of normal fibroblasts. Oncogene 16(9):1113\u20131123","journal-title":"Oncogene"},{"issue":"7","key":"1100_CR4","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nrc2440","volume":"8","author":"F d\u2019Adda di Fagagna","year":"2008","unstructured":"d\u2019Adda di Fagagna F (2008) Living on a break: cellular senescence as a DNA-damage response. Nat Rev Cancer 8(7):512\u201322","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"1100_CR5","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1474-9726.2009.00481.x","volume":"8","author":"C Wang","year":"2009","unstructured":"Wang C et al (2009) DNA damage response and cellular senescence in tissues of aging mice. Aging Cell 8(3):311\u2013323","journal-title":"Aging Cell"},{"issue":"1","key":"1100_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.mad.2004.09.034","volume":"126","author":"T von Zglinicki","year":"2005","unstructured":"von Zglinicki T et al (2005) Human cell senescence as a DNA damage response. Mech Ageing Dev 126(1):111\u2013117","journal-title":"Mech Ageing Dev"},{"key":"1100_CR7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1749-6632.2000.tb06639.x","volume":"908","author":"T von Zglinicki","year":"2000","unstructured":"von Zglinicki T (2000) Role of oxidative stress in telomere length regulation and replicative senescence. Ann N Y Acad Sci 908:99\u2013110","journal-title":"Ann N Y Acad Sci"},{"issue":"Pt 11","key":"1100_CR8","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1242\/jcs.01097","volume":"117","author":"DJ Kurz","year":"2004","unstructured":"Kurz DJ et al (2004) Chronic oxidative stress compromises telomere integrity and accelerates the onset of senescence in human endothelial cells. J Cell Sci 117(Pt 11):2417\u20132426","journal-title":"J Cell Sci"},{"issue":"5","key":"1100_CR9","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.molmed.2010.03.003","volume":"16","author":"A Freund","year":"2010","unstructured":"Freund A et al (2010) Inflammatory networks during cellular senescence: causes and consequences. Trends Mol Med 16(5):238\u2013246","journal-title":"Trends Mol Med"},{"issue":"1","key":"1100_CR10","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41392-021-00646-9","volume":"6","author":"X Zhu","year":"2021","unstructured":"Zhu X et al (2021) Inflammation, epigenetics, and metabolism converge to cell senescence and ageing: the regulation and intervention. Signal Transduct Target Ther 6(1):245","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"1100_CR11","doi-asserted-by":"publisher","first-page":"e110","DOI":"10.1371\/journal.pbio.0050110","volume":"5","author":"JF Passos","year":"2007","unstructured":"Passos JF et al (2007) Mitochondrial dysfunction accounts for the stochastic heterogeneity in telomere-dependent senescence. PLoS Biol 5(5):e110","journal-title":"PLoS Biol"},{"issue":"3","key":"1100_CR12","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S0531-5565(00)00083-8","volume":"35","author":"F Bringold","year":"2000","unstructured":"Bringold F, Serrano M (2000) Tumor suppressors and oncogenes in cellular senescence. Exp Gerontol 35(3):317\u2013329","journal-title":"Exp Gerontol"},{"issue":"10","key":"1100_CR13","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1056\/NEJMra062285","volume":"355","author":"WJ Mooi","year":"2006","unstructured":"Mooi WJ, Peeper DS (2006) Oncogene-induced cell senescence\u2013halting on the road to cancer. N Engl J Med 355(10):1037\u20131046","journal-title":"N Engl J Med"},{"issue":"18","key":"1100_CR14","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1101\/gad.1346005","volume":"19","author":"T de Lange","year":"2005","unstructured":"de Lange T (2005) Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 19(18):2100\u20132110","journal-title":"Genes Dev"},{"issue":"3","key":"1100_CR15","doi-asserted-by":"publisher","first-page":"558","DOI":"10.3390\/cancers12030558","volume":"12","author":"N Srinivas","year":"2020","unstructured":"Srinivas N, Rachakonda S, Kumar R (2020) Telomeres and telomere length: a general overview. Cancers (Basel) 12(3):558","journal-title":"Cancers (Basel)"},{"issue":"1","key":"1100_CR16","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1006\/excr.1995.1306","volume":"220","author":"RC Allsopp","year":"1995","unstructured":"Allsopp RC et al (1995) Telomere shortening is associated with cell division in vitro and in vivo. Exp Cell Res 220(1):194\u2013200","journal-title":"Exp Cell Res"},{"issue":"2","key":"1100_CR17","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3390\/ijms21020446","volume":"21","author":"A Campos","year":"2020","unstructured":"Campos A, Clemente-Blanco A (2020) Cell cycle and DNA repair regulation in the damage response: protein phosphatases take over the reins. Int J Mol Sci 21(2):446","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1100_CR18","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/ncb2466","volume":"14","author":"M Fumagalli","year":"2012","unstructured":"Fumagalli M et al (2012) Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation. Nat Cell Biol 14(4):355\u2013365","journal-title":"Nat Cell Biol"},{"key":"1100_CR19","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/ncomms1708","volume":"3","author":"G Hewitt","year":"2012","unstructured":"Hewitt G et al (2012) Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence. Nat Commun 3:708","journal-title":"Nat Commun"},{"key":"1100_CR20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.gde.2014.06.009","volume":"26","author":"F Rossiello","year":"2014","unstructured":"Rossiello F et al (2014) Irreparable telomeric DNA damage and persistent DDR signalling as a shared causative mechanism of cellular senescence and ageing. Curr Opin Genet Dev 26:89\u201395","journal-title":"Curr Opin Genet Dev"},{"issue":"13","key":"1100_CR21","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1002\/1873-3468.13498","volume":"593","author":"J Chapman","year":"2019","unstructured":"Chapman J, Fielder E, Passos JF (2019) Mitochondrial dysfunction and cell senescence: deciphering a complex relationship. FEBS Lett 593(13):1566\u20131579","journal-title":"FEBS Lett"},{"issue":"2","key":"1100_CR22","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1210\/er.2009-0026","volume":"31","author":"RH Houtkooper","year":"2010","unstructured":"Houtkooper RH et al (2010) The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways. Endocr Rev 31(2):194\u2013223","journal-title":"Endocr Rev"},{"issue":"2","key":"1100_CR23","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.cmet.2013.07.006","volume":"18","author":"MP Murphy","year":"2013","unstructured":"Murphy MP (2013) Mitochondrial dysfunction indirectly elevates ROS production by the endoplasmic reticulum. Cell Metab 18(2):145\u2013146","journal-title":"Cell Metab"},{"issue":"2","key":"1100_CR24","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1161\/01.CIR.96.2.614","volume":"96","author":"HK Mohazzab","year":"1997","unstructured":"Mohazzab HK, Kaminski PM, Wolin MS (1997) Lactate and PO2 modulate superoxide anion production in bovine cardiac myocytes: potential role of NADH oxidase. Circulation 96(2):614\u2013620","journal-title":"Circulation"},{"issue":"5","key":"1100_CR25","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/1873-3468.12902","volume":"592","author":"R Stefanatos","year":"2018","unstructured":"Stefanatos R, Sanz A (2018) The role of mitochondrial ROS in the aging brain. FEBS Lett 592(5):743\u2013758","journal-title":"FEBS Lett"},{"issue":"2","key":"1100_CR26","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1152\/physrev.00020.2018","volume":"99","author":"A Calcinotto","year":"2019","unstructured":"Calcinotto A et al (2019) Cellular senescence: aging, cancer, and injury. Physiol Rev 99(2):1047\u20131078","journal-title":"Physiol Rev"},{"issue":"4","key":"1100_CR27","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.cell.2019.10.005","volume":"179","author":"V Gorgoulis","year":"2019","unstructured":"Gorgoulis V et al (2019) Cellular senescence: defining a path forward. Cell 179(4):813\u2013827","journal-title":"Cell"},{"issue":"6","key":"1100_CR28","doi-asserted-by":"publisher","first-page":"151108","DOI":"10.1016\/j.ejcb.2020.151108","volume":"99","author":"NS Mohamad Kamal","year":"2020","unstructured":"Mohamad Kamal NS et al (2020) Aging of the cells: Insight into cellular senescence and detection methods. Eur J Cell Biol 99(6):151108","journal-title":"Eur J Cell Biol"},{"issue":"11","key":"1100_CR29","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1007\/s11033-016-4065-0","volume":"43","author":"MY Terzi","year":"2016","unstructured":"Terzi MY, Izmirli M, Gogebakan B (2016) The cell fate: senescence or quiescence. Mol Biol Rep 43(11):1213\u20131220","journal-title":"Mol Biol Rep"},{"issue":"21","key":"1100_CR30","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1101\/gad.8.21.2540","volume":"8","author":"A Di Leonardo","year":"1994","unstructured":"Di Leonardo A et al (1994) DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev 8(21):2540\u20132551","journal-title":"Genes Dev"},{"issue":"23","key":"1100_CR31","doi-asserted-by":"publisher","first-page":"jcs216804","DOI":"10.1242\/jcs.216804","volume":"131","author":"C Hinze","year":"2018","unstructured":"Hinze C, Boucrot E (2018) Endocytosis in proliferating, quiescent and terminally differentiated cells. J Cell Sci 131(23):jcs216804","journal-title":"J Cell Sci"},{"key":"1100_CR32","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3389\/fgene.2018.00247","volume":"9","author":"AS Wang","year":"2018","unstructured":"Wang AS, Dreesen O (2018) Biomarkers of cellular senescence and skin aging. Front Genet 9:247","journal-title":"Front Genet"},{"issue":"38","key":"1100_CR33","doi-asserted-by":"publisher","first-page":"5220","DOI":"10.1038\/sj.onc.1209615","volume":"25","author":"C Giacinti","year":"2006","unstructured":"Giacinti C, Giordano A (2006) RB and cell cycle progression. Oncogene 25(38):5220\u20135227","journal-title":"Oncogene"},{"issue":"2","key":"1100_CR34","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1101\/gad.949802","volume":"16","author":"B Ren","year":"2002","unstructured":"Ren B et al (2002) E2F integrates cell cycle progression with DNA repair, replication, and G(2)\/M checkpoints. Genes Dev 16(2):245\u2013256","journal-title":"Genes Dev"},{"issue":"7","key":"1100_CR35","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrc3960","volume":"15","author":"NE Sharpless","year":"2015","unstructured":"Sharpless NE, Sherr CJ (2015) Forging a signature of in vivo senescence. Nat Rev Cancer 15(7):397\u2013408","journal-title":"Nat Rev Cancer"},{"key":"1100_CR36","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/0014-4827(61)90192-6","volume":"25","author":"L Hayflick","year":"1961","unstructured":"Hayflick L, Moorhead PS (1961) The serial cultivation of human diploid cell strains. Exp Cell Res 25:585\u2013621","journal-title":"Exp Cell Res"},{"issue":"1","key":"1100_CR37","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0047-6374(76)90007-5","volume":"5","author":"Y Mitsui","year":"1976","unstructured":"Mitsui Y, Schneider EL (1976) Relationship between cell replication and volume in senescent human diploid fibroblasts. Mech Ageing Dev 5(1):45\u201356","journal-title":"Mech Ageing Dev"},{"issue":"46","key":"1100_CR38","doi-asserted-by":"publisher","first-page":"eabk0271","DOI":"10.1126\/sciadv.abk0271","volume":"7","author":"J Lengefeld","year":"2021","unstructured":"Lengefeld J et al (2021) Cell size is a determinant of stem cell potential during aging. Sci Adv 7(46):eabk0271","journal-title":"Sci Adv"},{"issue":"1","key":"1100_CR39","doi-asserted-by":"publisher","first-page":"47","DOI":"10.5483\/BMBRep.2019.52.1.293","volume":"52","author":"EC Kim","year":"2019","unstructured":"Kim EC, Kim JR (2019) Senotherapeutics: emerging strategy for healthy aging and age-related disease. BMB Rep 52(1):47\u201355","journal-title":"BMB Rep"},{"issue":"1","key":"1100_CR40","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.cell.2017.02.031","volume":"169","author":"MP Baar","year":"2017","unstructured":"Baar MP et al (2017) Targeted apoptosis of senescent cells restores tissue homeostasis in response to chemotoxicity and aging. Cell 169(1):132\u2013147","journal-title":"Cell"},{"key":"1100_CR41","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ebiom.2017.04.013","volume":"21","author":"JL Kirkland","year":"2017","unstructured":"Kirkland JL, Tchkonia T (2017) Cellular senescence: a translational perspective. EBioMedicine 21:21\u201328","journal-title":"EBioMedicine"},{"issue":"2","key":"1100_CR42","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s10522-018-9785-1","volume":"20","author":"R Kumar","year":"2019","unstructured":"Kumar R et al (2019) Epigallocatechin gallate suppresses premature senescence of preadipocytes by inhibition of PI3K\/Akt\/mTOR pathway and induces senescent cell death by regulation of Bax\/Bcl-2 pathway. Biogerontology 20(2):171\u2013189","journal-title":"Biogerontology"},{"key":"1100_CR43","doi-asserted-by":"crossref","unstructured":"Cherry C et al (2023) Transfer learning in a biomaterial fibrosis model identifies in vivo senescence heterogeneity and contributions to vascularization and matrix production across species and diverse pathologies. Geroscience. Online ahead of print","DOI":"10.1007\/s11357-023-00785-7"},{"key":"1100_CR44","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.neurobiolaging.2022.08.014","volume":"120","author":"M Ng","year":"2022","unstructured":"Ng M, Hazrati LN (2022) Evidence of sex differences in cellular senescence. Neurobiol Aging 120:88\u2013104","journal-title":"Neurobiol Aging"},{"issue":"17","key":"1100_CR45","doi-asserted-by":"publisher","first-page":"21066","DOI":"10.18632\/aging.203519","volume":"13","author":"M Rall-Scharpf","year":"2021","unstructured":"Rall-Scharpf M et al (2021) Sex-specific differences in DNA double-strand break repair of cycling human lymphocytes during aging. Aging (Albany NY) 13(17):21066\u201321089","journal-title":"Aging (Albany NY)"},{"key":"1100_CR46","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0076-6879(08)01406-7","volume":"442","author":"W Malorni","year":"2008","unstructured":"Malorni W et al (2008) Analyzing lipid raft dynamics during cell apoptosis. Methods Enzymol 442:125\u2013140","journal-title":"Methods Enzymol"},{"key":"1100_CR47","doi-asserted-by":"publisher","first-page":"1027116","DOI":"10.3389\/fnins.2022.1027116","volume":"16","author":"N Schwab","year":"2022","unstructured":"Schwab N et al (2022) Neurons and glial cells acquire a senescent signature after repeated mild traumatic brain injury in a sex-dependent manner. Front Neurosci 16:1027116","journal-title":"Front Neurosci"},{"issue":"11","key":"1100_CR48","doi-asserted-by":"publisher","first-page":"bqap192","DOI":"10.1210\/endocr\/bqab192","volume":"162","author":"L Broestl","year":"2021","unstructured":"Broestl L, Rubin JB (2021) Sexual differentiation specifies cellular responses to DNA damage. Endocrinology 162(11):bqap192","journal-title":"Endocrinology"},{"issue":"6","key":"1100_CR49","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.cell.2008.03.038","volume":"133","author":"JC Acosta","year":"2008","unstructured":"Acosta JC et al (2008) Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 133(6):1006\u20131018","journal-title":"Cell"},{"issue":"2","key":"1100_CR50","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1158\/0008-5472.CAN-05-1716","volume":"66","author":"C Bavik","year":"2006","unstructured":"Bavik C et al (2006) The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms. Cancer Res 66(2):794\u2013802","journal-title":"Cancer Res"},{"issue":"12","key":"1100_CR51","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1371\/journal.pbio.0060301","volume":"6","author":"JP Coppe","year":"2008","unstructured":"Coppe JP et al (2008) Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 6(12):2853\u20132868","journal-title":"PLoS Biol"},{"issue":"9","key":"1100_CR52","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1172\/JCI22475","volume":"114","author":"J Krishnamurthy","year":"2004","unstructured":"Krishnamurthy J et al (2004) Ink4a\/Arf expression is a biomarker of aging. J Clin Invest 114(9):1299\u20131307","journal-title":"J Clin Invest"},{"issue":"7","key":"1100_CR53","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1158\/0008-5472.CAN-06-3452","volume":"67","author":"D Liu","year":"2007","unstructured":"Liu D, Hornsby PJ (2007) Senescent human fibroblasts increase the early growth of xenograft tumors via matrix metalloproteinase secretion. Cancer Res 67(7):3117\u20133126","journal-title":"Cancer Res"},{"issue":"8","key":"1100_CR54","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/ncb1909","volume":"11","author":"F Rodier","year":"2009","unstructured":"Rodier F et al (2009) Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat Cell Biol 11(8):973\u2013979","journal-title":"Nat Cell Biol"},{"issue":"1","key":"1100_CR55","doi-asserted-by":"publisher","first-page":"e3000599","DOI":"10.1371\/journal.pbio.3000599","volume":"18","author":"N Basisty","year":"2020","unstructured":"Basisty N et al (2020) A proteomic atlas of senescence-associated secretomes for aging biomarker development. PLoS Biol 18(1):e3000599","journal-title":"PLoS Biol"},{"key":"1100_CR56","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","volume":"5","author":"JP Coppe","year":"2010","unstructured":"Coppe JP et al (2010) The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol 5:99\u2013118","journal-title":"Annu Rev Pathol"},{"issue":"4","key":"1100_CR57","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1083\/jcb.201206006","volume":"201","author":"AR Davalos","year":"2013","unstructured":"Davalos AR et al (2013) p53-dependent release of Alarmin HMGB1 is a central mediator of senescent phenotypes. J Cell Biol 201(4):613\u2013629","journal-title":"J Cell Biol"},{"issue":"13","key":"1100_CR58","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1016\/j.celrep.2019.08.049","volume":"28","author":"CD Wiley","year":"2019","unstructured":"Wiley CD et al (2019) SILAC analysis reveals increased secretion of hemostasis-related factors by senescent cells. Cell Rep 28(13):3329\u20133337","journal-title":"Cell Rep"},{"issue":"10","key":"1100_CR59","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.3390\/ijms20102547","volume":"20","author":"R Jakhar","year":"2019","unstructured":"Jakhar R, Crasta K (2019) Exosomes as emerging pro-tumorigenic mediators of the senescence-associated secretory phenotype. Int J Mol Sci 20(10):2547","journal-title":"Int J Mol Sci"},{"issue":"10","key":"1100_CR60","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.7150\/thno.18915","volume":"7","author":"Q Lei","year":"2017","unstructured":"Lei Q et al (2017) Microvesicles as potential biomarkers for the identification of senescence in human mesenchymal stem cells. Theranostics 7(10):2673\u20132689","journal-title":"Theranostics"},{"key":"1100_CR61","doi-asserted-by":"publisher","first-page":"101275","DOI":"10.1016\/j.smim.2019.04.003","volume":"40","author":"L Prata","year":"2018","unstructured":"Prata L et al (2018) Senescent cell clearance by the immune system: Emerging therapeutic opportunities. Semin Immunol 40:101275","journal-title":"Semin Immunol"},{"issue":"6","key":"1100_CR62","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.cmet.2021.03.008","volume":"33","author":"CD Wiley","year":"2021","unstructured":"Wiley CD et al (2021) Oxylipin biosynthesis reinforces cellular senescence and allows detection of senolysis. Cell Metab 33(6):1124-1136.e5","journal-title":"Cell Metab"},{"issue":"1","key":"1100_CR63","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13578-022-00815-5","volume":"12","author":"Y Sun","year":"2022","unstructured":"Sun Y et al (2022) The multifaceted role of the SASP in atherosclerosis: from mechanisms to therapeutic opportunities. Cell Biosci 12(1):74","journal-title":"Cell Biosci"},{"key":"1100_CR64","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fncel.2020.00016","volume":"14","author":"C Martinez-Cue","year":"2020","unstructured":"Martinez-Cue C, Rueda N (2020) Cellular senescence in neurodegenerative diseases. Front Cell Neurosci 14:16","journal-title":"Front Cell Neurosci"},{"issue":"12","key":"1100_CR65","doi-asserted-by":"publisher","first-page":"e133668","DOI":"10.1172\/jci.insight.133668","volume":"5","author":"MJ Schafer","year":"2020","unstructured":"Schafer MJ et al (2020) The senescence-associated secretome as an indicator of age and medical risk. JCI Insight 5(12):e133668","journal-title":"JCI Insight"},{"issue":"1","key":"1100_CR66","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12966-016-0432-4","volume":"13","author":"E Hoare","year":"2016","unstructured":"Hoare E et al (2016) The associations between sedentary behaviour and mental health among adolescents: a systematic review. Int J Behav Nutr Phys Act 13(1):108","journal-title":"Int J Behav Nutr Phys Act"},{"issue":"7742","key":"1100_CR67","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41586-018-0784-9","volume":"566","author":"M De Cecco","year":"2019","unstructured":"De Cecco M et al (2019) L1 drives IFN in senescent cells and promotes age-associated inflammation. Nature 566(7742):73\u201378","journal-title":"Nature"},{"issue":"6","key":"1100_CR68","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.devcel.2014.11.012","volume":"31","author":"M Demaria","year":"2014","unstructured":"Demaria M et al (2014) An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA. Dev Cell 31(6):722\u2013733","journal-title":"Dev Cell"},{"key":"1100_CR69","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/978-1-4939-8931-7_6","volume":"1896","author":"N Malaquin","year":"2019","unstructured":"Malaquin N, Tu V, Rodier F (2019) Assessing functional roles of the senescence-associated secretory phenotype (SASP). Methods Mol Biol 1896:45\u201355","journal-title":"Methods Mol Biol"},{"issue":"3","key":"1100_CR70","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/embor.2009.22","volume":"10","author":"AR Young","year":"2009","unstructured":"Young AR, Narita M (2009) SASP reflects senescence. EMBO Rep 10(3):228\u2013230","journal-title":"EMBO Rep"},{"issue":"2","key":"1100_CR71","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.cell.2013.03.020","volume":"153","author":"A Lujambio","year":"2013","unstructured":"Lujambio A et al (2013) Non-cell-autonomous tumor suppression by p53. Cell 153(2):449\u2013460","journal-title":"Cell"},{"issue":"7370","key":"1100_CR72","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nature10523","volume":"478","author":"HJ Kang","year":"2011","unstructured":"Kang HJ et al (2011) Spatio-temporal transcriptome of the human brain. Nature 478(7370):483\u2013489","journal-title":"Nature"},{"issue":"7128","key":"1100_CR73","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nature05529","volume":"445","author":"W Xue","year":"2007","unstructured":"Xue W et al (2007) Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445(7128):656\u2013660","journal-title":"Nature"},{"issue":"5","key":"1100_CR74","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.cell.2013.10.019","volume":"155","author":"D Mu\u00f1oz-Esp\u00edn","year":"2013","unstructured":"Mu\u00f1oz-Esp\u00edn D et al (2013) Programmed cell senescence during mammalian embryonic development. Cell 155(5):1104\u20131118","journal-title":"Cell"},{"issue":"5","key":"1100_CR75","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.cell.2013.10.041","volume":"155","author":"M Storer","year":"2013","unstructured":"Storer M et al (2013) Senescence is a developmental mechanism that contributes to embryonic growth and patterning. Cell 155(5):1119\u20131130","journal-title":"Cell"},{"issue":"11","key":"1100_CR76","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1002\/jbmr.2892","volume":"31","author":"JN Farr","year":"2016","unstructured":"Farr JN et al (2016) Identification of senescent cells in the bone microenvironment. J Bone Miner Res 31(11):1920\u20131929","journal-title":"J Bone Miner Res"},{"issue":"17","key":"1100_CR77","doi-asserted-by":"publisher","first-page":"e93771","DOI":"10.1172\/jci.insight.93771","volume":"2","author":"M Piemontese","year":"2017","unstructured":"Piemontese M et al (2017) Old age causes de novo intracortical bone remodeling and porosity in mice. JCI Insight 2(17):e93771","journal-title":"JCI Insight"},{"issue":"9","key":"1100_CR78","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1038\/nm.4385","volume":"23","author":"JN Farr","year":"2017","unstructured":"Farr JN et al (2017) Targeting cellular senescence prevents age-related bone loss in mice. Nat Med 23(9):1072\u20131079","journal-title":"Nat Med"},{"issue":"7875","key":"1100_CR79","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/s41586-021-03795-7","volume":"597","author":"TH Ambrosi","year":"2021","unstructured":"Ambrosi TH et al (2021) Aged skeletal stem cells generate an inflammatory degenerative niche. Nature 597(7875):256\u2013262","journal-title":"Nature"},{"issue":"5","key":"1100_CR80","doi-asserted-by":"publisher","first-page":"e13602","DOI":"10.1111\/acel.13602","volume":"21","author":"A Chandra","year":"2022","unstructured":"Chandra A et al (2022) Targeted clearance of p21- but not p16-positive senescent cells prevents radiation-induced osteoporosis and increased marrow adiposity. Aging Cell 21(5):e13602","journal-title":"Aging Cell"},{"issue":"1","key":"1100_CR81","doi-asserted-by":"publisher","first-page":"4827","DOI":"10.1038\/s41467-022-32552-1","volume":"13","author":"D Saul","year":"2022","unstructured":"Saul D et al (2022) A new gene set identifies senescent cells and predicts senescence-associated pathways across tissues. Nat Commun 13(1):4827","journal-title":"Nat Commun"},{"issue":"6937","key":"1100_CR82","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nature01629","volume":"423","author":"M Eriksson","year":"2003","unstructured":"Eriksson M et al (2003) Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature 423(6937):293\u2013298","journal-title":"Nature"},{"issue":"10","key":"1100_CR83","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/nrm.2017.68","volume":"18","author":"N Kubben","year":"2017","unstructured":"Kubben N, Misteli T (2017) Shared molecular and cellular mechanisms of premature ageing and ageing-associated diseases. Nat Rev Mol Cell Biol 18(10):595\u2013609","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"9","key":"1100_CR84","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.molmed.2021.06.011","volume":"27","author":"M Rieckher","year":"2021","unstructured":"Rieckher M, Garinis GA, Schumacher B (2021) Molecular pathology of rare progeroid diseases. Trends Mol Med 27(9):907\u2013922","journal-title":"Trends Mol Med"},{"issue":"6","key":"1100_CR85","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1042\/BST20170141","volume":"45","author":"C Strandgren","year":"2017","unstructured":"Strandgren C et al (2017) Emerging candidate treatment strategies for Hutchinson-Gilford progeria syndrome. Biochem Soc Trans 45(6):1279\u20131293","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"1100_CR86","doi-asserted-by":"publisher","first-page":"e13285","DOI":"10.1111\/acel.13285","volume":"20","author":"S Squarzoni","year":"2021","unstructured":"Squarzoni S et al (2021) Interleukin-6 neutralization ameliorates symptoms in prematurely aged mice. Aging Cell 20(1):e13285","journal-title":"Aging Cell"},{"key":"1100_CR87","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.bone.2019.03.002","volume":"125","author":"WS Hambright","year":"2019","unstructured":"Hambright WS et al (2019) Murine models of accelerated aging and musculoskeletal disease. Bone 125:122\u2013127","journal-title":"Bone"},{"issue":"10","key":"1100_CR88","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1093\/gerona\/glt046","volume":"68","author":"RL Jilka","year":"2013","unstructured":"Jilka RL (2013) The relevance of mouse models for investigating age-related bone loss in humans. J Gerontol A 68(10):1209\u20131217","journal-title":"J Gerontol A"},{"issue":"7372","key":"1100_CR89","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nature10600","volume":"479","author":"DJ Baker","year":"2011","unstructured":"Baker DJ et al (2011) Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479(7372):232\u2013236","journal-title":"Nature"},{"key":"1100_CR90","doi-asserted-by":"publisher","first-page":"7219","DOI":"10.3402\/pba.v1i0.7219","volume":"1","author":"ME Dolle","year":"2011","unstructured":"Dolle ME et al (2011) Broad segmental progeroid changes in short-lived Ercc1(-\/Delta7) mice. Pathobiol Aging Age Relat Dis 1:7219","journal-title":"Pathobiol Aging Age Relat Dis"},{"issue":"10","key":"1100_CR91","doi-asserted-by":"publisher","first-page":"e1004686","DOI":"10.1371\/journal.pgen.1004686","volume":"10","author":"S Barnhoorn","year":"2014","unstructured":"Barnhoorn S et al (2014) Cell-autonomous progeroid changes in conditional mouse models for repair endonuclease XPG deficiency. PLoS Genet 10(10):e1004686","journal-title":"PLoS Genet"},{"issue":"7122","key":"1100_CR92","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/nature05456","volume":"444","author":"LJ Niedernhofer","year":"2006","unstructured":"Niedernhofer LJ et al (2006) A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis. Nature 444(7122):1038\u20131043","journal-title":"Nature"},{"issue":"5","key":"1100_CR93","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1002\/jbmr.1851","volume":"28","author":"Q Chen","year":"2013","unstructured":"Chen Q et al (2013) DNA damage drives accelerated bone aging via an NF-\u03baB-dependent mechanism. J Bone Miner Res 28(5):1214\u20131228","journal-title":"J Bone Miner Res"},{"issue":"24","key":"1100_CR94","doi-asserted-by":"publisher","first-page":"24481","DOI":"10.18632\/aging.202321","volume":"12","author":"A Wong","year":"2020","unstructured":"Wong A, Kieu T, Robbins PD (2020) The Ercc<i>1<\/i><sup>-\/\u0394<\/sup> mouse model of accelerated senescence and aging for identification and testing of novel senotherapeutic interventions. Aging 12(24):24481\u201324483","journal-title":"Aging"},{"key":"1100_CR95","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1146\/annurev-genom-082908-150150","volume":"10","author":"BS Davies","year":"2009","unstructured":"Davies BS et al (2009) The posttranslational processing of prelamin A and disease. Annu Rev Genomics Hum Genet 10:153\u2013174","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"5628","key":"1100_CR96","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1126\/science.1084125","volume":"300","author":"A De Sandre-Giovannoli","year":"2003","unstructured":"De Sandre-Giovannoli A et al (2003) Lamin a truncation in Hutchinson-Gilford progeria. Science 300(5628):2055","journal-title":"Science"},{"issue":"5","key":"1100_CR97","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1111\/j.0022-202X.2005.23846.x","volume":"125","author":"CL Moulson","year":"2005","unstructured":"Moulson CL et al (2005) Homozygous and compound heterozygous mutations in ZMPSTE24 cause the laminopathy restrictive dermopathy. J Invest Dermatol 125(5):913\u2013919","journal-title":"J Invest Dermatol"},{"issue":"8","key":"1100_CR98","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1038\/ejhg.2013.258","volume":"22","author":"CL Navarro","year":"2014","unstructured":"Navarro CL et al (2014) New ZMPSTE24 (FACE1) mutations in patients affected with restrictive dermopathy or related progeroid syndromes and mutation update. Eur J Hum Genet 22(8):1002\u20131011","journal-title":"Eur J Hum Genet"},{"key":"1100_CR99","doi-asserted-by":"publisher","first-page":"111788","DOI":"10.1016\/j.mrfmmm.2022.111788","volume":"825","author":"D Sengupta","year":"2022","unstructured":"Sengupta D, Sengupta K (2022) Lamin A and telomere maintenance in aging: two to tango. Mutat Res 825:111788","journal-title":"Mutat Res"},{"issue":"52","key":"1100_CR100","doi-asserted-by":"publisher","first-page":"39741","DOI":"10.1074\/jbc.R600033200","volume":"281","author":"SG Young","year":"2006","unstructured":"Young SG et al (2006) Prelamin A farnesylation and progeroid syndromes. J Biol Chem 281(52):39741\u201339745","journal-title":"J Biol Chem"},{"issue":"9","key":"1100_CR101","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.tig.2012.06.001","volume":"28","author":"V Butin-Israeli","year":"2012","unstructured":"Butin-Israeli V et al (2012) Nuclear lamin functions and disease. Trends Genet 28(9):464\u2013471","journal-title":"Trends Genet"},{"issue":"1","key":"1100_CR102","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jsb.2011.11.007","volume":"177","author":"L Gerace","year":"2012","unstructured":"Gerace L, Huber MD (2012) Nuclear lamina at the crossroads of the cytoplasm and nucleus. J Struct Biol 177(1):24\u201331","journal-title":"J Struct Biol"},{"issue":"1","key":"1100_CR103","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1146\/annurev-biochem-060614-034115","volume":"84","author":"Y Gruenbaum","year":"2015","unstructured":"Gruenbaum Y, Foisner R (2015) Lamins: nuclear intermediate filament proteins with fundamental functions in nuclear mechanics and genome regulation. Annu Rev Biochem 84(1):131\u2013164","journal-title":"Annu Rev Biochem"},{"issue":"3","key":"1100_CR104","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1101\/gad.255968.114","volume":"29","author":"S Osmanagic-Myers","year":"2015","unstructured":"Osmanagic-Myers S, Dechat T, Foisner R (2015) Lamins at the crossroads of mechanosignaling. Genes Dev 29(3):225\u2013237","journal-title":"Genes Dev"},{"issue":"20","key":"1100_CR105","doi-asserted-by":"publisher","first-page":"13049","DOI":"10.1073\/pnas.192460799","volume":"99","author":"MO Bergo","year":"2002","unstructured":"Bergo MO et al (2002) <i>Zmpste24<\/i> deficiency in mice causes spontaneous bone fractures, muscle weakness, and a prelamin A processing defect. Proc Natl Acad Sci USA 99(20):13049\u201313054","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"1100_CR106","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/gerona\/glp089","volume":"64","author":"D Rivas","year":"2009","unstructured":"Rivas D et al (2009) Accelerated features of age-related bone loss in zmpste24 metalloproteinase-deficient mice. J Gerontol A 64(10):1015\u20131024","journal-title":"J Gerontol A"},{"issue":"4","key":"1100_CR107","doi-asserted-by":"publisher","first-page":"e19313","DOI":"10.1371\/journal.pone.0019313","volume":"6","author":"W Li","year":"2011","unstructured":"Li W et al (2011) Decreased bone formation and osteopenia in lamin a\/c-deficient mice. PLoS ONE 6(4):e19313","journal-title":"PLoS ONE"},{"issue":"32","key":"1100_CR108","doi-asserted-by":"publisher","first-page":"22817","DOI":"10.18632\/oncotarget.25071","volume":"9","author":"C Gargiuli","year":"2018","unstructured":"Gargiuli C et al (2018) Lamins and bone disorders: current understanding and perspectives. Oncotarget 9(32):22817\u201322831","journal-title":"Oncotarget"},{"issue":"20","key":"1100_CR109","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1101\/gad.197954.112","volume":"26","author":"FG Osorio","year":"2012","unstructured":"Osorio FG et al (2012) Nuclear lamina defects cause ATM-dependent NF-\u03baB activation and link accelerated aging to a systemic inflammatory response. Genes Dev 26(20):2311\u20132324","journal-title":"Genes Dev"},{"issue":"12","key":"1100_CR110","doi-asserted-by":"publisher","first-page":"e13486","DOI":"10.1111\/acel.13486","volume":"20","author":"L Zhang","year":"2021","unstructured":"Zhang L et al (2021) Novel small molecule inhibition of IKK\/NF-\u03baB activation reduces markers of senescence and improves healthspan in mouse models of aging. Aging Cell 20(12):e13486","journal-title":"Aging Cell"},{"issue":"9","key":"1100_CR111","doi-asserted-by":"publisher","first-page":"e2118695119","DOI":"10.1073\/pnas.2118695119","volume":"119","author":"Y Wang","year":"2022","unstructured":"Wang Y et al (2022) Abolishing the prelamin A ZMPSTE24 cleavage site leads to progeroid phenotypes with near-normal longevity in mice. Proc Natl Acad Sci USA 119(9):e2118695119","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"1100_CR112","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.tig.2016.09.005","volume":"32","author":"SW Criscione","year":"2016","unstructured":"Criscione SW, Teo YV, Neretti N (2016) The chromatin landscape of cellular senescence. Trends Genet 32(11):751\u2013761","journal-title":"Trends Genet"},{"issue":"4","key":"1100_CR113","doi-asserted-by":"publisher","first-page":"264","DOI":"10.18632\/aging.100651","volume":"6","author":"A Infante","year":"2014","unstructured":"Infante A et al (2014) Prelamin A accumulation and stress conditions induce impaired Oct-1 activity and autophagy in prematurely aged human mesenchymal stem cell. Aging (Albany NY) 6(4):264\u2013280","journal-title":"Aging (Albany NY)"},{"issue":"5","key":"1100_CR114","first-page":"1","volume":"50","author":"JY Lee","year":"2018","unstructured":"Lee JY et al (2018) GATA4-dependent regulation of the secretory phenotype via MCP-1 underlies lamin A-mediated human mesenchymal stem cell aging. Exp Mol Med 50(5):1\u201312","journal-title":"Exp Mol Med"},{"issue":"3","key":"1100_CR115","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/00005792-196605000-00001","volume":"45","author":"CJ Epstein","year":"1966","unstructured":"Epstein CJ et al (1966) Werner\u2019s syndrome a review of its symptomatology, natural history, pathologic features, genetics and relationship to the natural aging process. Medicine (Baltimore) 45(3):177\u2013221","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"1100_CR116","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/ggi.14078","volume":"21","author":"S Mori","year":"2021","unstructured":"Mori S et al (2021) Management guideline for Werner syndrome 2020. 4. Osteoporosis associated with Werner syndrome. Geriatr Gerontol Int 21(2):146\u2013149","journal-title":"Geriatr Gerontol Int"},{"issue":"19","key":"1100_CR117","doi-asserted-by":"publisher","first-page":"8437","DOI":"10.1128\/MCB.24.19.8437-8446.2004","volume":"24","author":"X Du","year":"2004","unstructured":"Du X et al (2004) Telomere shortening exposes functions for the mouse Werner and Bloom syndrome genes. Mol Cell Biol 24(19):8437\u20138446","journal-title":"Mol Cell Biol"},{"issue":"1","key":"1100_CR118","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1474-9726.2007.00350.x","volume":"7","author":"RJ Pignolo","year":"2008","unstructured":"Pignolo RJ et al (2008) Defects in telomere maintenance molecules impair osteoblast differentiation and promote osteoporosis. Aging Cell 7(1):23\u201331","journal-title":"Aging Cell"},{"key":"1100_CR119","first-page":"181","volume":"47","author":"J Salk","year":"1981","unstructured":"Salk J et al (1981) Theoretical and practical considerations in the application of killed poliovirus vaccine for the control of paralytic poliomyelitis. Dev Biol Stand 47:181\u2013198","journal-title":"Dev Biol Stand"},{"issue":"2","key":"1100_CR120","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jalz.2013.06.009","volume":"10","author":"CY Cheung","year":"2014","unstructured":"Cheung CY et al (2014) Microvascular network alterations in the retina of patients with Alzheimer\u2019s disease. Alzheimers Dement 10(2):135\u2013142","journal-title":"Alzheimers Dement"},{"key":"1100_CR121","doi-asserted-by":"publisher","first-page":"597566","DOI":"10.3389\/fgene.2021.597566","volume":"12","author":"Y Zhang","year":"2021","unstructured":"Zhang Y et al (2021) The distinct function of p21Waf1\/Cip1 With p16Ink4a in modulating aging phenotypes of Werner Syndrome by affecting tissue homeostasis. Front Genet 12:597566","journal-title":"Front Genet"},{"issue":"6\u20137","key":"1100_CR122","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1159\/000516386","volume":"161","author":"R Gudmundsrud","year":"2021","unstructured":"Gudmundsrud R et al (2021) Crosstalk among DNA damage, mitochondrial dysfunction, impaired mitophagy, stem cell attrition, and senescence in the accelerated ageing disorder Werner syndrome. Cytogenet Genome Res 161(6\u20137):297\u2013304","journal-title":"Cytogenet Genome Res"},{"issue":"1","key":"1100_CR123","doi-asserted-by":"publisher","first-page":"5456","DOI":"10.1038\/s41467-022-33012-6","volume":"13","author":"Y Tian","year":"2022","unstructured":"Tian Y et al (2022) WRN promotes bone development and growth by unwinding SHOX-G-quadruplexes via its helicase activity in Werner Syndrome. Nat Commun 13(1):5456","journal-title":"Nat Commun"},{"key":"1100_CR124","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/bs.ircmb.2019.03.005","volume":"346","author":"X Liu","year":"2019","unstructured":"Liu X, Wan M (2019) A tale of the good and bad: cell senescence in bone homeostasis and disease. Int Rev Cell Mol Biol 346:97\u2013128","journal-title":"Int Rev Cell Mol Biol"},{"issue":"1","key":"1100_CR125","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1038\/s41467-017-01509-0","volume":"8","author":"C Li","year":"2017","unstructured":"Li C et al (2017) Programmed cell senescence in skeleton during late puberty. Nat Commun 8(1):1312","journal-title":"Nat Commun"},{"issue":"5275","key":"1100_CR126","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1126\/science.273.5275.663","volume":"273","author":"B Lanske","year":"1996","unstructured":"Lanske B et al (1996) PTH\/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science 273(5275):663\u2013666","journal-title":"Science"},{"issue":"4","key":"1100_CR127","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1177\/10454411000110040201","volume":"11","author":"TL McCarthy","year":"2000","unstructured":"McCarthy TL, Ji C, Centrella M (2000) Links among growth factors, hormones, and nuclear factors with essential roles in bone formation. Crit Rev Oral Biol Med 11(4):409\u2013422","journal-title":"Crit Rev Oral Biol Med"},{"key":"1100_CR128","doi-asserted-by":"publisher","first-page":"576","DOI":"10.3389\/fendo.2020.00576","volume":"11","author":"LM Ward","year":"2020","unstructured":"Ward LM (2020) Glucocorticoid-induced osteoporosis: why kids are different. Front Endocrinol (Lausanne) 11:576","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"1100_CR129","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nrendo.2015.89","volume":"11","author":"JN Farr","year":"2015","unstructured":"Farr JN, Khosla S (2015) Skeletal changes through the lifespan\u2013from growth to senescence. Nat Rev Endocrinol 11(9):513\u2013521","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"1100_CR130","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1152\/physrev.00011.2015","volume":"96","author":"K Hartmann","year":"2016","unstructured":"Hartmann K et al (2016) Molecular actions of glucocorticoids in cartilage and bone during health, disease, and steroid therapy. Physiol Rev 96(2):409\u2013447","journal-title":"Physiol Rev"},{"issue":"1","key":"1100_CR131","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1038\/s41467-021-22131-1","volume":"12","author":"X Liu","year":"2021","unstructured":"Liu X et al (2021) Osteoclasts protect bone blood vessels against senescence through the angiogenin\/plexin-B2 axis. Nat Commun 12(1):1832","journal-title":"Nat Commun"},{"issue":"4","key":"1100_CR132","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.cmet.2023.03.005","volume":"35","author":"X Liu","year":"2023","unstructured":"Liu X et al (2023) Oxylipin-PPARgamma-initiated adipocyte senescence propagates secondary senescence in the bone marrow. Cell Metab 35(4):667\u2013684","journal-title":"Cell Metab"},{"issue":"4","key":"1100_CR133","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.cmet.2023.03.009","volume":"35","author":"L Tong","year":"2023","unstructured":"Tong L, Chen D (2023) Senescence of bone marrow fat cells: a new clue for glucocorticoid-induced bone deterioration. Cell Metab 35(4):551\u2013553","journal-title":"Cell Metab"},{"issue":"6","key":"1100_CR134","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41574-023-00843-2","volume":"19","author":"S Starling","year":"2023","unstructured":"Starling S (2023) Glucocorticoid-induced bone loss linked with marrow adipocyte senescence. Nat Rev Endocrinol 19(6):312","journal-title":"Nat Rev Endocrinol"},{"issue":"10182","key":"1100_CR135","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/S0140-6736(19)30417-9","volume":"393","author":"DJ Hunter","year":"2019","unstructured":"Hunter DJ, Bierma-Zeinstra S (2019) Osteoarthritis. Lancet 393(10182):1745\u20131759","journal-title":"Lancet"},{"issue":"9991","key":"1100_CR136","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/S0140-6736(14)60802-3","volume":"386","author":"S Glyn-Jones","year":"2015","unstructured":"Glyn-Jones S et al (2015) Osteoarthritis. Lancet 386(9991):376\u2013387","journal-title":"Lancet"},{"issue":"11","key":"1100_CR137","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1038\/s12276-021-00710-y","volume":"53","author":"Y Cho","year":"2021","unstructured":"Cho Y et al (2021) Disease-modifying therapeutic strategies in osteoarthritis: current status and future directions. Exp Mol Med 53(11):1689\u20131696","journal-title":"Exp Mol Med"},{"key":"1100_CR138","doi-asserted-by":"crossref","unstructured":"Oo,WM, Hunter DJ (2022) Repurposed and investigational disease-modifying drugs in osteoarthritis (DMOADs). Ther Adv Musculoskelet Dis 14:1759720x221090297","DOI":"10.1177\/1759720X221090297"},{"issue":"6","key":"1100_CR139","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/nm.4324","volume":"23","author":"OH Jeon","year":"2017","unstructured":"Jeon OH et al (2017) Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment. Nat Med 23(6):775\u2013781","journal-title":"Nat Med"},{"key":"1100_CR140","doi-asserted-by":"publisher","first-page":"102213","DOI":"10.1016\/j.coph.2022.102213","volume":"64","author":"EM Astrike-Davis","year":"2022","unstructured":"Astrike-Davis EM, Coryell P, Loeser RF (2022) Targeting cellular senescence as a novel treatment for osteoarthritis. Curr Opin Pharmacol 64:102213","journal-title":"Curr Opin Pharmacol"},{"issue":"7","key":"1100_CR141","first-page":"996","volume":"11","author":"Y He","year":"2022","unstructured":"He Y et al (2022) Potential methods of targeting cellular aging hallmarks to reverse osteoarthritic phenotype of chondrocytes. Biology (Basel) 11(7):996","journal-title":"Biology (Basel)"},{"issue":"1","key":"1100_CR142","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41413-021-00164-y","volume":"9","author":"M Wan","year":"2021","unstructured":"Wan M, Gray-Gaillard EF, Elisseeff JH (2021) Cellular senescence in musculoskeletal homeostasis, diseases, and regeneration. Bone Res 9(1):41","journal-title":"Bone Res"},{"issue":"10","key":"1100_CR143","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/s43587-021-00121-8","volume":"1","author":"NS Gasek","year":"2021","unstructured":"Gasek NS et al (2021) Strategies for targeting senescent cells in human disease. Nat Aging 1(10):870\u2013879","journal-title":"Nat Aging"},{"issue":"1","key":"1100_CR144","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13075-022-02859-x","volume":"24","author":"Y Liu","year":"2022","unstructured":"Liu Y et al (2022) Senescence in osteoarthritis: from mechanism to potential treatment. Arthritis Res Ther 24(1):174","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"1100_CR145","doi-asserted-by":"publisher","first-page":"5493","DOI":"10.1172\/JCI134091","volume":"130","author":"HJ Faust","year":"2020","unstructured":"Faust HJ et al (2020) IL-17 and immunologically induced senescence regulate response to injury in osteoarthritis. J Clin Invest 130(10):5493\u20135507","journal-title":"J Clin Invest"},{"issue":"11","key":"1100_CR146","doi-asserted-by":"publisher","first-page":"e10686","DOI":"10.1002\/jbm4.10686","volume":"6","author":"MC Alfonzo","year":"2022","unstructured":"Alfonzo MC et al (2022) Extracellular vesicles as communicators of senescence in musculoskeletal aging. JBMR Plus 6(11):e10686","journal-title":"JBMR Plus"},{"key":"1100_CR147","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/164_2021_555","volume":"274","author":"S Chaib","year":"2022","unstructured":"Chaib S, Tchkonia T, Kirkland JL (2022) Obesity, senescence, and senolytics. Handb Exp Pharmacol 274:165\u2013180","journal-title":"Handb Exp Pharmacol"},{"issue":"5","key":"1100_CR148","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/joim.13141","volume":"288","author":"JL Kirkland","year":"2020","unstructured":"Kirkland JL, Tchkonia T (2020) Senolytic drugs: from discovery to translation. J Intern Med 288(5):518\u2013536","journal-title":"J Intern Med"},{"issue":"1","key":"1100_CR149","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nrrheum.2010.197","volume":"7","author":"RJ Lories","year":"2011","unstructured":"Lories RJ, Luyten FP (2011) The bone-cartilage unit in osteoarthritis. Nat Rev Rheumatol 7(1):43\u201349","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"1100_CR150","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00167-010-1071-y","volume":"18","author":"H Madry","year":"2010","unstructured":"Madry H (2010) The subchondral bone: a new frontier in articular cartilage repair. Knee Surg Sports Traumatol Arthrosc 18(4):417\u2013418","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"issue":"5","key":"1100_CR151","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1159\/000213866","volume":"43","author":"AJ Bailey","year":"1997","unstructured":"Bailey AJ, Mansell JP (1997) Do subchondral bone changes exacerbate or precede articular cartilage destruction in osteoarthritis of the elderly? Gerontology 43(5):296\u2013304","journal-title":"Gerontology"},{"issue":"6","key":"1100_CR152","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/ncprheum0505","volume":"3","author":"JP Mansell","year":"2007","unstructured":"Mansell JP, Collins C, Bailey AJ (2007) Bone, not cartilage, should be the major focus in osteoarthritis. Nat Clin Pract Rheumatol 3(6):306\u2013307","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"7","key":"1100_CR153","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.joca.2007.01.020","volume":"15","author":"DA Walsh","year":"2007","unstructured":"Walsh DA et al (2007) Angiogenesis in the synovium and at the osteochondral junction in osteoarthritis. Osteoarthr Cartil 15(7):743\u2013751","journal-title":"Osteoarthr Cartil"},{"issue":"9","key":"1100_CR154","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1136\/annrheumdis-2015-207923","volume":"75","author":"Z Cui","year":"2016","unstructured":"Cui Z et al (2016) Halofuginone attenuates osteoarthritis by inhibition of TGF-\u03b2 activity and H-type vessel formation in subchondral bone. Ann Rheum Dis 75(9):1714\u20131721","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1100_CR155","doi-asserted-by":"publisher","first-page":"2855","DOI":"10.1038\/s41598-018-21184-5","volume":"8","author":"H Fang","year":"2018","unstructured":"Fang H et al (2018) Early changes of articular cartilage and subchondral bone in the DMM mouse model of osteoarthritis. Sci Rep 8(1):2855","journal-title":"Sci Rep"},{"issue":"5","key":"1100_CR156","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/jbmr.3388","volume":"33","author":"J Lu","year":"2018","unstructured":"Lu J et al (2018) Positive-feedback regulation of subchondral H-type vessel formation by chondrocyte promotes osteoarthritis development in mice. J Bone Miner Res 33(5):909\u2013920","journal-title":"J Bone Miner Res"},{"issue":"1","key":"1100_CR157","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/nyas.13000","volume":"1376","author":"L Xie","year":"2016","unstructured":"Xie L et al (2016) Systemic neutralization of TGF-\u03b2 attenuates osteoarthritis. Ann N Y Acad Sci 1376(1):53\u201364","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"1100_CR158","doi-asserted-by":"publisher","first-page":"e135446","DOI":"10.1172\/jci.insight.135446","volume":"5","author":"W Su","year":"2020","unstructured":"Su W et al (2020) Angiogenesis stimulated by elevated PDGF-BB in subchondral bone contributes to osteoarthritis development. JCI Insight 5(8):e135446","journal-title":"JCI Insight"},{"issue":"10","key":"1100_CR159","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1097\/01.bot.0000246468.80635.ef","volume":"20","author":"TD Brown","year":"2006","unstructured":"Brown TD et al (2006) Posttraumatic osteoarthritis: a first estimate of incidence, prevalence, and burden of disease. J Orthop Trauma 20(10):739\u2013744","journal-title":"J Orthop Trauma"},{"issue":"4","key":"1100_CR160","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.jor.2016.06.029","volume":"13","author":"R Chadha","year":"2016","unstructured":"Chadha R (2016) Revealed aspect of metabolic osteoarthritis. J Orthop 13(4):347\u2013351","journal-title":"J Orthop"},{"issue":"2","key":"1100_CR161","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1097\/BOR.0000000000000373","volume":"29","author":"A Courties","year":"2017","unstructured":"Courties A, Sellam J, Berenbaum F (2017) Metabolic syndrome-associated osteoarthritis. Curr Opin Rheumatol 29(2):214\u2013222","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"1100_CR162","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/1756-185X.13061","volume":"20","author":"S Farnaghi","year":"2017","unstructured":"Farnaghi S et al (2017) Cholesterol metabolism in pathogenesis of osteoarthritis disease. Int J Rheum Dis 20(2):131\u2013140","journal-title":"Int J Rheum Dis"},{"issue":"12","key":"1100_CR163","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/nrrheum.2012.135","volume":"8","author":"Q Zhuo","year":"2012","unstructured":"Zhuo Q et al (2012) Metabolic syndrome meets osteoarthritis. Nat Rev Rheumatol 8(12):729\u2013737","journal-title":"Nat Rev Rheumatol"},{"key":"1100_CR164","doi-asserted-by":"publisher","first-page":"e79773","DOI":"10.7554\/eLife.79773","volume":"11","author":"W Su","year":"2022","unstructured":"Su W et al (2022) Senescent preosteoclast secretome promotes metabolic syndrome associated osteoarthritis through cyclooxygenase 2. eLife 11:e79773","journal-title":"eLife"},{"key":"1100_CR165","doi-asserted-by":"publisher","first-page":"e66532","DOI":"10.7554\/eLife.66532","volume":"10","author":"Q Sun","year":"2021","unstructured":"Sun Q et al (2021) Parathyroid hormone attenuates osteoarthritis pain by remodeling subchondral bone in mice. Elife 10:e66532","journal-title":"Elife"},{"issue":"6","key":"1100_CR166","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/nm.3143","volume":"19","author":"G Zhen","year":"2013","unstructured":"Zhen G et al (2013) Inhibition of TGF-\u03b2 signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis. Nat Med 19(6):704\u2013712","journal-title":"Nat Med"},{"issue":"3","key":"1100_CR167","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1172\/JCI121561","volume":"129","author":"S Zhu","year":"2019","unstructured":"Zhu S et al (2019) Subchondral bone osteoclasts induce sensory innervation and osteoarthritis pain. J Clin Invest 129(3):1076\u20131093","journal-title":"J Clin Invest"},{"issue":"7","key":"1100_CR168","doi-asserted-by":"publisher","first-page":"e125019","DOI":"10.1172\/jci.insight.125019","volume":"4","author":"OH Jeon","year":"2019","unstructured":"Jeon OH et al (2019) Senescence cell\u2013associated extracellular vesicles serve as osteoarthritis disease and therapeutic markers. JCI Insight 4(7):e125019","journal-title":"JCI Insight"},{"issue":"13","key":"1100_CR169","doi-asserted-by":"publisher","first-page":"6638","DOI":"10.1158\/0008-5472.CAN-06-0661","volume":"66","author":"S Jain","year":"2006","unstructured":"Jain S, Chakraborty G, Kundu GC (2006) The crucial role of cyclooxygenase-2 in osteopontin-induced protein kinase C alpha\/c-Src\/IkappaB kinase alpha\/beta-dependent prostate tumor progression and angiogenesis. Cancer Res 66(13):6638\u20136648","journal-title":"Cancer Res"},{"issue":"1","key":"1100_CR170","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13046-018-0839-7","volume":"37","author":"Y Li","year":"2018","unstructured":"Li Y et al (2018) IL-33 facilitates proliferation of colorectal cancer dependent on COX2\/PGE(2). J Exp Clin Cancer Res 37(1):196","journal-title":"J Exp Clin Cancer Res"},{"issue":"3","key":"1100_CR171","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/jne.12000","volume":"25","author":"N Hamzic","year":"2013","unstructured":"Hamzic N, Blomqvist A, Nilsberth C (2013) Immune-induced expression of lipocalin-2 in brain endothelial cells: relationship with interleukin-6, cyclooxygenase-2 and the febrile response. J Neuroendocrinol 25(3):271\u2013280","journal-title":"J Neuroendocrinol"},{"issue":"4","key":"1100_CR172","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.3892\/ijo.2017.3883","volume":"50","author":"V Panagopoulos","year":"2017","unstructured":"Panagopoulos V et al (2017) Inflammatory peroxidases promote breast cancer progression in mice via regulation of the tumour microenvironment. Int J Oncol 50(4):1191\u20131200","journal-title":"Int J Oncol"},{"issue":"12","key":"1100_CR173","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1093\/carcin\/bgp244","volume":"30","author":"MH Chien","year":"2009","unstructured":"Chien MH et al (2009) Vascular endothelial growth factor-C (VEGF-C) promotes angiogenesis by induction of COX-2 in leukemic cells via the VEGF-R3\/JNK\/AP-1 pathway. Carcinogenesis 30(12):2005\u20132013","journal-title":"Carcinogenesis"},{"issue":"6","key":"1100_CR174","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1002\/jcp.25644","volume":"232","author":"YP Su","year":"2017","unstructured":"Su YP et al (2017) Low shear stress attenuates COX-2 expression induced by resistin in human osteoarthritic chondrocytes. J Cell Physiol 232(6):1448\u20131457","journal-title":"J Cell Physiol"},{"issue":"5","key":"1100_CR175","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.jvs.2004.01.041","volume":"39","author":"MJ Englesbe","year":"2004","unstructured":"Englesbe MJ et al (2004) Interleukin-1beta inhibits PDGF-BB-induced migration by cooperating with PDGF-BB to induce cyclooxygenase-2 expression in baboon aortic smooth muscle cells. J Vasc Surg 39(5):1091\u20131096","journal-title":"J Vasc Surg"},{"issue":"2","key":"1100_CR176","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1101\/cshperspect.a028415","volume":"10","author":"S Rose-John","year":"2018","unstructured":"Rose-John S (2018) Interleukin-6 family cytokines. Cold Spring Harb Perspect Biol 10(2):284","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"1100_CR177","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.canlet.2018.03.050","volume":"426","author":"AC Chang","year":"2018","unstructured":"Chang AC et al (2018) Osteoblast-secreted WISP-1 promotes adherence of prostate cancer cells to bone via the VCAM-1\/integrin alpha4beta1 system. Cancer Lett 426:47\u201356","journal-title":"Cancer Lett"},{"issue":"1","key":"1100_CR178","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.4110\/in.2018.18.e8","volume":"18","author":"DS Amarasekara","year":"2018","unstructured":"Amarasekara DS et al (2018) Regulation of osteoclast differentiation by cytokine networks. Immune Netw 18(1):e8","journal-title":"Immune Netw"},{"issue":"3","key":"1100_CR179","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/jbmr.4215","volume":"36","author":"X Zhao","year":"2021","unstructured":"Zhao X et al (2021) Myeloperoxidase controls bone turnover by suppressing osteoclast differentiation through modulating reactive oxygen species level. J Bone Miner Res 36(3):591\u2013603","journal-title":"J Bone Miner Res"},{"key":"1100_CR180","doi-asserted-by":"publisher","first-page":"782382","DOI":"10.1155\/2015\/782382","volume":"2015","author":"P Ruscitti","year":"2015","unstructured":"Ruscitti P et al (2015) The role of IL-1beta in the bone loss during rheumatic diseases. Mediators Inflamm 2015:782382","journal-title":"Mediators Inflamm"},{"issue":"20","key":"1100_CR181","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.4155\/fmc-2018-0234","volume":"10","author":"V Myrianthopoulos","year":"2018","unstructured":"Myrianthopoulos V (2018) The emerging field of senotherapeutic drugs. Future Med Chem 10(20):2369\u20132372","journal-title":"Future Med Chem"},{"issue":"5","key":"1100_CR182","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1111\/febs.16350","volume":"290","author":"L Zhang","year":"2023","unstructured":"Zhang L et al (2023) Targeting cellular senescence with senotherapeutics: senolytics and senomorphics. FEBS J 290(5):1362\u20131383","journal-title":"FEBS J"},{"issue":"4","key":"1100_CR183","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/acel.12344","volume":"14","author":"Y Zhu","year":"2015","unstructured":"Zhu Y et al (2015) The Achilles\u2019 heel of senescent cells: from transcriptome to senolytic drugs. Aging Cell 14(4):644\u2013658","journal-title":"Aging Cell"},{"issue":"1","key":"1100_CR184","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41536-021-00145-z","volume":"6","author":"Y Zhou","year":"2021","unstructured":"Zhou Y et al (2021) Senolytics improve bone forming potential of bone marrow mesenchymal stem cells from aged mice. NPJ Regen Med 6(1):34","journal-title":"NPJ Regen Med"},{"key":"1100_CR185","doi-asserted-by":"crossref","unstructured":"Liu J, et al (2022) Age-associated callus senescent cells produce TGF-beta1 that inhibits fracture healing in aged mice. J Clin Invest 132(8)","DOI":"10.1172\/JCI148073"},{"key":"1100_CR186","doi-asserted-by":"publisher","first-page":"e69958","DOI":"10.7554\/eLife.69958","volume":"10","author":"D Saul","year":"2021","unstructured":"Saul D et al (2021) Modulation of fracture healing by the transient accumulation of senescent cells. Elife 10:e69958","journal-title":"Elife"},{"key":"1100_CR187","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ebiom.2018.09.015","volume":"36","author":"MJ Yousefzadeh","year":"2018","unstructured":"Yousefzadeh MJ et al (2018) Fisetin is a senotherapeutic that extends health and lifespan. EBioMedicine 36:18\u201328","journal-title":"EBioMedicine"},{"issue":"1","key":"1100_CR188","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/nm.4010","volume":"22","author":"J Chang","year":"2016","unstructured":"Chang J et al (2016) Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice. Nat Med 22(1):78\u201383","journal-title":"Nat Med"},{"issue":"3","key":"1100_CR189","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/acel.12445","volume":"15","author":"Y Zhu","year":"2016","unstructured":"Zhu Y et al (2016) Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors. Aging Cell 15(3):428\u2013435","journal-title":"Aging Cell"},{"key":"1100_CR190","doi-asserted-by":"publisher","first-page":"11190","DOI":"10.1038\/ncomms11190","volume":"7","author":"R Yosef","year":"2016","unstructured":"Yosef R et al (2016) Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL. Nat Commun 7:11190","journal-title":"Nat Commun"},{"issue":"1","key":"1100_CR191","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/hep.29464","volume":"67","author":"A Moncsek","year":"2018","unstructured":"Moncsek A et al (2018) Targeting senescent cholangiocytes and activated fibroblasts with B-cell lymphoma-extra large inhibitors ameliorates fibrosis in multidrug resistance 2 gene knockout (Mdr2(-\/-) ) mice. Hepatology 67(1):247\u2013259","journal-title":"Hepatology"},{"issue":"14","key":"1100_CR192","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.3390\/cancers13143585","volume":"13","author":"C Schwarzenbach","year":"2021","unstructured":"Schwarzenbach C et al (2021) Targeting c-IAP1, c-IAP2, and Bcl-2 eliminates senescent glioblastoma cells following temozolomide treatment. Cancers (Basel) 13(14):3585","journal-title":"Cancers (Basel)"},{"issue":"1","key":"1100_CR193","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/s41467-017-00314-z","volume":"8","author":"H Fuhrmann-Stroissnigg","year":"2017","unstructured":"Fuhrmann-Stroissnigg H et al (2017) Identification of HSP90 inhibitors as a novel class of senolytics. Nat Commun 8(1):422","journal-title":"Nat Commun"},{"key":"1100_CR194","doi-asserted-by":"publisher","first-page":"111565","DOI":"10.1016\/j.mad.2021.111565","volume":"199","author":"ML Doolittle","year":"2021","unstructured":"Doolittle ML et al (2021) The role of senolytics in osteoporosis and other skeletal pathologies. Mech Ageing Dev 199:111565","journal-title":"Mech Ageing Dev"},{"issue":"2","key":"1100_CR195","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s11357-017-9970-1","volume":"39","author":"KM Perrott","year":"2017","unstructured":"Perrott KM et al (2017) Apigenin suppresses the senescence-associated secretory phenotype and paracrine effects on breast cancer cells. Geroscience 39(2):161\u2013173","journal-title":"Geroscience"},{"issue":"4","key":"1100_CR196","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.bcp.2015.06.013","volume":"96","author":"H Lim","year":"2015","unstructured":"Lim H, Park H, Kim HP (2015) Effects of flavonoids on senescence-associated secretory phenotype formation from bleomycin-induced senescence in BJ fibroblasts. Biochem Pharmacol 96(4):337\u2013348","journal-title":"Biochem Pharmacol"},{"issue":"10","key":"1100_CR197","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/j.1753-4887.2008.00109.x","volume":"66","author":"MD Knutson","year":"2008","unstructured":"Knutson MD, Leeuwenburgh C (2008) Resveratrol and novel potent activators of SIRT1: effects on aging and age-related diseases. Nutr Rev 66(10):591\u2013596","journal-title":"Nutr Rev"},{"issue":"1","key":"1100_CR198","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cmet.2020.04.001","volume":"32","author":"AS Kulkarni","year":"2020","unstructured":"Kulkarni AS, Gubbi S, Barzilai N (2020) Benefits of metformin in attenuating the hallmarks of aging. Cell Metab 32(1):15\u201330","journal-title":"Cell Metab"},{"issue":"4","key":"1100_CR199","doi-asserted-by":"publisher","first-page":"E760","DOI":"10.1152\/ajpendo.00543.2019","volume":"320","author":"FF Pan","year":"2021","unstructured":"Pan FF et al (2021) Apigenin promotes osteogenic differentiation of mesenchymal stem cells and accelerates bone fracture healing via activating Wnt\/beta-catenin signaling. Am J Physiol Endocrinol Metab 320(4):E760\u2013E771","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"1100_CR200","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s10616-014-9694-3","volume":"67","author":"T Goto","year":"2015","unstructured":"Goto T et al (2015) Apigenin inhibits osteoblastogenesis and osteoclastogenesis and prevents bone loss in ovariectomized mice. Cytotechnology 67(2):357\u2013365","journal-title":"Cytotechnology"},{"key":"1100_CR201","doi-asserted-by":"publisher","first-page":"6741995","DOI":"10.1155\/2022\/6741995","volume":"2022","author":"F Tang","year":"2022","unstructured":"Tang F et al (2022) Research on the mechanism of kaempferol for treating senile osteoporosis by network pharmacology and molecular docking. Evid Based Complement Altern Med 2022:6741995","journal-title":"Evid Based Complement Altern Med"},{"issue":"6","key":"1100_CR202","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/jcb.22649","volume":"110","author":"L Yang","year":"2010","unstructured":"Yang L et al (2010) Kaempferol stimulates bone sialoprotein gene transcription and new bone formation. J Cell Biochem 110(6):1342\u20131355","journal-title":"J Cell Biochem"},{"issue":"1\u20132","key":"1100_CR203","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.mce.2008.02.027","volume":"289","author":"R Trivedi","year":"2008","unstructured":"Trivedi R et al (2008) Kaempferol has osteogenic effect in ovariectomized adult Sprague-Dawley rats. Mol Cell Endocrinol 289(1\u20132):85\u201393","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"1100_CR204","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.pharep.2017.05.002","volume":"69","author":"B Nowak","year":"2017","unstructured":"Nowak B et al (2017) Oral administration of kaempferol inhibits bone loss in rat model of ovariectomy-induced osteopenia. Pharmacol Rep 69(5):1113\u20131119","journal-title":"Pharmacol Rep"},{"key":"1100_CR205","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.nut.2017.12.003","volume":"53","author":"S Adhikary","year":"2018","unstructured":"Adhikary S et al (2018) Dietary flavonoid kaempferol inhibits glucocorticoid-induced bone loss by promoting osteoblast survival. Nutrition 53:64\u201376","journal-title":"Nutrition"},{"issue":"6","key":"1100_CR206","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.bcp.2005.12.023","volume":"71","author":"JL Pang","year":"2006","unstructured":"Pang JL et al (2006) Differential activity of kaempferol and quercetin in attenuating tumor necrosis factor receptor family signaling in bone cells. Biochem Pharmacol 71(6):818\u2013826","journal-title":"Biochem Pharmacol"},{"key":"1100_CR207","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.intimp.2016.12.020","volume":"43","author":"J Zhu","year":"2017","unstructured":"Zhu J et al (2017) Kaempferol slows intervertebral disc degeneration by modifying LPS-induced osteogenesis\/adipogenesis imbalance and inflammation response in BMSCs. Int Immunopharmacol 43:236\u2013242","journal-title":"Int Immunopharmacol"},{"issue":"7\u20138","key":"1100_CR208","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.lfs.2010.12.009","volume":"88","author":"WF Chiou","year":"2011","unstructured":"Chiou WF et al (2011) 8-Prenylkaempferol accelerates osteoblast maturation through bone morphogenetic protein-2\/p38 pathway to activate Runx2 transcription. Life Sci 88(7\u20138):335\u2013342","journal-title":"Life Sci"},{"key":"1100_CR209","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.cbi.2018.02.022","volume":"284","author":"SB Lee","year":"2018","unstructured":"Lee SB et al (2018) Kaempferol 7-O-beta-D-glucoside isolated from the leaves of Cudrania tricuspidata inhibits LPS-induced expression of pro-inflammatory mediators through inactivation of NF-kappaB, AP-1, and JAK-STAT in RAW 264.7 macrophages. Chem Biol Interact 284:101\u2013111","journal-title":"Chem Biol Interact"},{"issue":"4","key":"1100_CR210","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1007\/s10753-014-9849-6","volume":"37","author":"WS Lee","year":"2014","unstructured":"Lee WS et al (2014) Kaempferol inhibits IL-1beta-stimulated, RANKL-mediated osteoclastogenesis via downregulation of MAPKs, c-Fos, and NFATc1. Inflammation 37(4):1221\u20131230","journal-title":"Inflammation"},{"key":"1100_CR211","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.2147\/DDDT.S227738","volume":"13","author":"SK Wong","year":"2019","unstructured":"Wong SK, Chin KY, Ima-Nirwana S (2019) The osteoprotective effects of kaempferol: the evidence from in vivo and in vitro studies. Drug Des Devel Ther 13:3497\u20133514","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"1100_CR212","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1080\/13510002.2019.1658376","volume":"24","author":"T Zhou","year":"2019","unstructured":"Zhou T et al (2019) Resveratrol improves osteogenic differentiation of senescent bone mesenchymal stem cells through inhibiting endogenous reactive oxygen species production via AMPK activation. Redox Rep 24(1):62\u201369","journal-title":"Redox Rep"},{"key":"1100_CR213","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.phrs.2016.05.015","volume":"111","author":"M Xu","year":"2016","unstructured":"Xu M, Tchkonia T, Kirkland JL (2016) Perspective: Targeting the JAK\/STAT pathway to fight age-related dysfunction. Pharmacol Res 111:152\u2013154","journal-title":"Pharmacol Res"},{"key":"1100_CR214","doi-asserted-by":"publisher","first-page":"650250","DOI":"10.3389\/fcell.2021.650250","volume":"9","author":"M Chen","year":"2021","unstructured":"Chen M et al (2021) Inhibition of JAK-STAT signaling pathway alleviates age-related phenotypes in tendon stem\/progenitor cells. Front Cell Dev Biol 9:650250","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"1100_CR215","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","volume":"6","author":"X Hu","year":"2021","unstructured":"Hu X et al (2021) The JAK\/STAT signaling pathway: from bench to clinic. Signal Transduct Target Ther 6(1):402","journal-title":"Signal Transduct Target Ther"},{"issue":"46","key":"1100_CR216","doi-asserted-by":"publisher","first-page":"E6301","DOI":"10.1073\/pnas.1515386112","volume":"112","author":"M Xu","year":"2015","unstructured":"Xu M et al (2015) JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age. Proc Natl Acad Sci USA 112(46):E6301\u2013E6310","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"1100_CR217","doi-asserted-by":"publisher","first-page":"e13122","DOI":"10.1111\/acel.13122","volume":"19","author":"A Griveau","year":"2020","unstructured":"Griveau A et al (2020) The JAK1\/2 inhibitor ruxolitinib delays premature aging phenotypes. Aging Cell 19(4):e13122","journal-title":"Aging Cell"},{"issue":"8","key":"1100_CR218","doi-asserted-by":"publisher","first-page":"1C21","DOI":"10.1007\/s00198-021-05871-0","volume":"32","author":"A Hamar","year":"2021","unstructured":"Hamar A et al (2021) Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis. Osteoporos Int 32(8):1C21-1629","journal-title":"Osteoporos Int"},{"issue":"20","key":"1100_CR219","doi-asserted-by":"publisher","first-page":"e147116","DOI":"10.1172\/JCI147116","volume":"131","author":"L Santhanam","year":"2021","unstructured":"Santhanam L et al (2021) Skeleton-secreted PDGF-BB mediates arterial stiffening. J Clin Invest 131(20):e147116","journal-title":"J Clin Invest"},{"key":"1100_CR220","doi-asserted-by":"crossref","unstructured":"Liu G, et al (2023) Elevated PDGF-BB from bone impairs hippocampal vasculature by inducing PDGFRbeta shedding from pericytes. Adv Sci (Weinh) e2206938","DOI":"10.1002\/advs.202206938"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-023-01100-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-023-01100-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-023-01100-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T13:03:44Z","timestamp":1688648624000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-023-01100-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,31]]},"references-count":220,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["1100"],"URL":"https:\/\/doi.org\/10.1007\/s00223-023-01100-4","relation":{},"ISSN":["1432-0827"],"issn-type":[{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,31]]},"assertion":[{"value":"31 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}